Denville, NJ — Diagenode, Inc., a leading global provider of complete solutions for epigenetics research, recently launched the industry’s first monoclonal antibody targeting CRISPR/Cas9. The antibody has been extensively validated for a number of applications including western blotting, immunofluorescence to determine protein localization, and immunoprecipitation applications such as chromatin immunoprecipitation. The CRISPR/Cas system has been […]

Manassas, VA — ATCC, the premier global biological materials resource and standards organization, announced today that it has received ISO 13485:2003 certification for the development, manufacture, and distribution of standards, controls, reagents and in vitro diagnostic test kits. Every day researchers in life science, medical diagnostics, applied sciences, and clinical drug development leverage ATCC’s expansive […]

RESEARCH TRIANGLE PARK, N.C.– Triangle Research Labs, LLC and Biopredic International have completed an agreement for TRL to distribute the No-Spin HepaRG™ cells in North America. The No-Spin HepaRG™ represent an important improvement over the original cryopreserved HepaRG™ cells introduced three years ago for ADMET analyses. The HepaRG™ are renewable and reproducible hepatic cells derived […]

SAN DIEGO — Organovo Holdings, Inc. (NYSE MKT: ONVO) (“Organovo”), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that Gregory T. Lucier has been appointed as a corporate advisor. In the role, Mr. Lucier will advise Chief Executive Officer Keith Murphy and the executive management team on various corporate issues. […]

New York, NY — Spring Mountain Capital, LP, a New York-based investment management firm, announced today that its private equity group structured and led a growth equity investment in IsoPlexis Corporation. IsoPlexis has developed a break-through single cell immunoassay and related software that provides in-depth understanding of immune and cancer cells. The Company’s advanced cell […]

Cambridge, UK — Horizon Discovery Group plc (LSE: HZD) (Horizon), the international life science company supplying research tools to organizations engaged in genomics research and the development of personalized medicines, today announced three of the world’s leading gene editing scientists have joined the Company’s Scientific Advisory Board (SAB). The scientists are Dr. Emmanuelle Charpentier, Dr. […]

Minneapolis — Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne), a leading global provider of life science reagents and clinical controls, announces the appointment of Brenda S. Furlow as Senior Vice President and General Counsel effective August 4, 2014. Ms. Furlow is a legal executive with experience in several globally diverse technology businesses, and has a broad […]

BOTHELL, Wash.– BioLife Solutions, Inc. BLFS -0.76% , a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced that the Company’s CryoStor clinical grade cell freeze media was evaluated in a multicenter biobanking study […]

Wilmington Massachusetts — Kapa Biosystems Strengthens Investment across Asia Pacific Region by Extending Exclusive Japanese Distribution Agreement with Nippon Genetics Latest agreement builds on continued commercial success of Kapa’s genomics product portfolio over the past seven years in the Japanese market WILMINGTON, Mass.–(BUSINESS WIRE)–Kapa Biosystems announced today that it has signed a new three-year exclusive […]

CAMBRIDGE, Massachusetts — — Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced the launch of its Variant Libraries product, which allows customers to test virtually any number of DNA variant combinations and examine structure-function relationships. Initial applications include antibody or peptide engineering, and later versions of […]